Supplementary Figure S4 from Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma
Year: 2026
Type: supplementary-materials
Abstract: SLC35A2 targeted degradation by dTag modification synergizes with Pola-V.
Authors: Sean R. Corcoran, James D. Phelan, Jaewoo Choi, Galina Shevchenko, Rachel E. Fenner, Xin Yu, Sebastian Scheich, Tony Hsiao, Vivian M. Morris, Evangelia K. Papachristou, Kamal Kishore, Clive S. D’Santos, Yanlong Ji, Stefania Pittaluga, George W. Wright, Henning Urlaub, Kuan-Ting Pan, Thomas Oellerich, Jagan Muppidi, Daniel J. Hodson, Louis M. Staudt
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7165017302
Cites:
Cited by:
Related to: